|
1) 日本肥満学会肥満症診断基準検討委員会. 新しい肥満の判定と肥満症の診断基準. 肥満研究. 2000; 6: 18-28
|
|
|
|
2) 日本肥満学会肥満症治療ガイドライン作成委員会. 肥満症治療ガイドライン2006. 肥満研究. 2006; 12: 10-5
|
|
|
|
|
|
3) メタボリックシンドローム診断基準検討委員会. メタボリックシンドロームの定義と診断基準. 日内会誌. 2005; 94: 794-809
|
|
|
|
|
4) 厚生労働省健康局. 標準的な健診・保健指導プログラム(確定版). 平成19年4月
|
|
|
|
|
|
5) Ryo M, Nakamura T, Funahashi T, et al. Health education “Hokenshido" program reduced metabolic syndrome in the Amagasaki Visceral Fat Study. Three-year follow-up study of 3, 174 Japanese employees. Intern Med. 2011; 50: 1643-8
|
|
|
|
|
|
6) 日本肥満学会肥満症診断基準検討委員会. 肥満症診断基準 2011. 肥満研究. 2011; 17: 1-78
|
|
|
|
|
|
7) 厚生労働省. 平成18年度国民健康・栄養調査報告. 東京: 第一出版; 2009
|
|
|
|
|
|
8) Chagnac A, Herman M, Zingerman B, et al. Obesity-induced glomerular hyperfiltlation: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant. 2008; 23: 3946-52
|
|
|
|
|
|
9) Gami AS, Howard DE, Olson EJ, et al. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med. 2005; 352: 1206-14
|
|
|
|
|
|
10) Kuniyoshi FH, Garcia-Touchard A, Gami AS, et al. Day-night varidation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol. 2008; 52: 343-6
|
|
|
|
|
|
11) Martin JM, Carriso SJ, Vicence E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365: 1046-53
|
|
|
|
|
|
12) 日本痛風・核酸代謝学会, ガイドライン改訂委員会. 高尿酸血症・痛風の治療ガイドライン. 第2版(2010年改訂)
|
|
|
|
|
|
13) Tamba S, Nishizawa H, Funahashi T, et al. Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Intern Med. 2008; 47: 1175-80
|
|
|
|
|
|
14) Goicoechea M, de Vinuesa SG, Verdallas U, et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol. 2010; 5: 1388-93
|
|
|
|
|
|
15) The Examination Committee of Criteria for “Obesity Disease" in Japan, Japan Society for Study of Obesity: New criteria for “obesity disease" in Japan. Circ J. 2002; 66: 987-92
|
|
|
|
|
|
16) Miyazaki T, Hirata M, Moriyama K, et al. Metabolic Syndrome in Japanese diagnosed with visceral fat measurement by computed tomography. Proc Japan Acad. 2005; 81(Ser B): 471-9
|
|
|
|
|
|
17) Oka R, Kobayashi J, Yagi K, et al. Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diab Res Clin Pract. 2008; 79: 474-81
|
|
|
|
|
|
18) Hiuge-Shimizu A, Kishida K, Funahashi T, et al. Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (The VACATION-J study), Ann Med. 2010 Oct 22. [Epub ahead of print]
|
|
|
|
|
|
19) Okauchi Y, Nishizawa H, Funahashi T, et al. Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care. 2007; 30: 2392-4
|
|
|
|
|
|
20) Fujimoto WY, Leonetti DL, Bergstrom RW, et al. Visceral adiposity and incident coronary artery disease in Japanese-American men. The ten-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care. 1999; 22: 1808-12
|
|
|
|
|
|
21) Hayashi T, Boyko EJ, McNeely MJ, et al. Visceral adiposity, not abdominal subcutaneous fat are, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes. 2008; 57; 1269-75
|
|
|
|
|
|
22) The Look AHEAD Reserch Group. Reduction in weight and cardiovascular disease risk factors in individuals with type2 diabetes, Diabetes Care. 2007; 30: 1374-83
|
|
|
|
|